Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.

about

Adoptive Induced Antigen-Specific Treg Cells Reverse Inflammation in Collagen-Induced Arthritis Mouse Model.

P2860

Q47572144-106F962C-C966-49A4-9110-CD2BBDDE5E6B

P2860

Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.

Item

http://www.wikidata.org/entity/Q38610068

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Tumor necrosis factor-α blocka ...... ssion in rheumatoid arthritis.

@en

type

Item

label

Tumor necrosis factor-α blocka ...... ssion in rheumatoid arthritis.

@en

prefLabel

Tumor necrosis factor-α blocka ...... ssion in rheumatoid arthritis.

@en

P1476

Tumor necrosis factor-α blocka ...... ession in rheumatoid arthritis

@en

P2093

Ming-Chi Lu

http://www.w3.org/2001/XMLSchema#string

Ning-Sheng Lai

http://www.w3.org/2001/XMLSchema#string

Shu-Fen Wu

http://www.w3.org/2001/XMLSchema#string

P2860

CD40-CD40 ligand

The CD40/CD154 receptor/ligand dyad

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis.

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

The impact of DMARD and anti-TNF therapy on functional characterization of short-term T-cell activation in patients with rheumatoid arthritis--a follow-up study.

IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter.

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

Natural regulatory T cells in autoimmunity.

Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis.

P304

e0183726

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183726

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chien-Hsueh Tung

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28837666

http://www.w3.org/2001/XMLSchema#string

P932

5570341

http://www.w3.org/2001/XMLSchema#string

Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.

about

P2860

P2860

Tumor necrosis factor-α blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932